Brief: OncoZenge Lacks Liquidity, Cites Investor Payment Delay
22/01/2026 08:02
Jan 22 (Reuters) - OncoZenge AB ONCOZ.ST: SAID ON WEDNESDAY INVESTOR SICHUAN YANGTIAN BIO-PHARMACEUTICAL CO, LTD UNABLE TO PAY SUBSCRIPTION PROCEEDS OF ABOUT SEK 9.1 MILLION BY END OF DEADLINE IN DIRECTED SHARE ISSUE PAYMENT IS EXPECTED TO BE MADE WITHIN ABOUT 30 DAYS CO LACKS SUFFICIENT LIQUIDITY TO COVER ITS OBLIGATIONS FOR COMING MONTH CO ACTIVELY EXPLORING OPTIONS TO ADDRESS LIQUIDITY SITUATION, SECURE SHORT-TERM FINANCING Source text for Workspace: nMFNRqmC1 Further company coverage: ONCZO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))